|I acknowledge that the exception of LifeVantage Corporate events, all events on this calendar are posted by individual distributors. Any event cancellation or alteration is solely up to the distributor that is hosting the event. LifeVantage is not liable for any direct, indirect, special, incidental or consequential damages arising from a cancellation or alteration of an event hosted by a distributor.|
LifeVantage is deeply rooted in science. Science is at the heart of everything we do. Our flagship product, Protandim®, the Nrf2 Synergizer®, has been validated by peer-reviewed studies conducted in the laboratories of respected universities such as The Ohio State University, LSU and the University of Colorado Denver. The results of these studies have been published in mainstream medical journals such as “Free Radical Biology & Medicine” and “Enzyme Research.” Below are summaries of these peer-reviewed studies:
Antioxidants for the Treatment of Patients with Severe Angioproliferative Pulmonary Hypertension?
Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge
Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.
The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy
The role of manganese superoxide dismutase in skin cancer
Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway
The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice
Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model
Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure
The chemopreventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis
Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim
Protandim does not influence alveolar epithelial permeability or intrapulmonary oxidative stress in human subjects with alcohol use disorders.
Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress.